InvestingPro Subscription Available at 2026s Lowest Price Ahead of Sale Deadline Provident PFS Q1 2026 Beat Revenue NA EPS Exceeds by Significant Terns Pharmaceuticals TERN Steady at 5295 Awaiting Next Catalyst 20260515 Coeptis COEP Trading at 1640 Key Decision Point 20260519 First FFBC Q1 2026 Earnings Beat Revenue NA EPS 071 UK Softens Russian Oil Sanctions Amid Rising Fuel Prices and Strait of Hormuz Tensions Encore ECPG Steady at 8061 Awaiting Next Catalyst 20260520 Berkshire Hathaway Returns to Airlines With 26 Billion Delta Stake Tulsi Gabbard Resignation as National Intelligence Director Could Introduce Policy Uncertainty EbolaDriven Isolation Mandate for DR Congo Players Raises Questions About World Cup Logistics and Economic Impact BristolMyers Squibb Draws Hedge Fund Interest with 425 Dividend Yield and AI Partnership Natural Gas Futures Decline as Weather Forecasts Warm for Early February Novartis Raises FullYear Guidance Signaling Strong Growth Prospects Robinhood Launches AI Agents for Automated Trading and Credit Card Spending CION Q1 2026 Earnings EPS Misses Estimates by 174 Stock Declines NuCana NCNA Q3 2024 Earnings EPS Surprise Beats Estimates Despite No Revenue FTAIN Q1 2026 Earnings Miss on Bottom Line as Preferred Shares Hold Steady APGE Q1 2026 Earnings Apogee Therapeutics Narrows Loss Per Share Stock Slips Slightly Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum UK Spy Chief Warns West Faces Moment of Consequence Geopolitical Risks Intensify CNM Q1 2026 Earnings Earnings Beat Driven by Strong Demand and Operational Efficiency